Results overview: Found 4 records in 0.01 seconds.
Articles, 2 records found
Research literature, 2 records found
Articles 2 records found  
1.
7 p, 1.2 MB Recombinant pharmaceuticals from microbial cells : a 2015 update / Sanchez-Garcia, Laura (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Martín, Lucas (Universitat Autònoma de Barcelona. Technology Transfer Office) ; Mangues, Ramon (Institut d'Investigacions Biomèdiques Sant Pau) ; Ferrer Miralles, Neus (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Vázquez Gómez, Esther (CIBER de Bioingeniería, Biomateriales y Nanomedicina (Barcelona)) ; Villaverde Corrales, Antonio (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to protein absence or malfunction. Since these pathologies cannot be yet regularly treated by gene therapy, the administration of functional proteins produced ex vivo is required. [...]
2016 - 10.1186/s12934-016-0437-3
Microbial cell factories, Vol. 15, Issue 33 (February 2016)  
2.
7 p, 774.5 KB Expanding the recombinant protein quality in Lactococcus lactis / Cano Garrido, Olivia (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Rueda, Fabián L. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Sànchez-García, Laura (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Ruiz-Ávila, Luis (Spherium Biomed S.L.) ; Bosser, Ramon (Spherium Biomed S.L.) ; Villaverde Corrales, Antonio (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; García Fruitós, Elena (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Background: Escherichia coli has been a main host for the production of recombinant proteins of biomedical interest, but conformational stress responses impose severe bottlenecks that impair the production of soluble, proteolytically stable versions of many protein species. [...]
2014 - 10.1186/s12934-014-0167-3
Microbial cell factories, Vol. 13 (2014) , p. 167  

Research literature 2 records found  
1.
242 p, 10.7 MB Engineering all-in-one protein-based nanoparticles for targeted cancer therapies / Sánchez García, Laura, 1992- autor. ; Villaverde Corrales, Antonio, supervisor acadèmic. ; Vázquez Gómez, Esther, supervisor acadèmic. ; Unzueta Elorza, Ugutz, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia.
Actualmente, las terapias convencionales contra el cáncer están lejos de ser ideales en cuanto a eficacia. Los fármacos actuales, formados por pequeños compuestos químicos se distribuyen indistintamente por todo el organismo, generando elevada toxicidad sistémica y dando lugar a efectos secundarios en tejidos sanos. [...]
Nowadays, conventional cancer therapies are far from being optimal in terms of efficacy. Current drugs are small chemical entities that equally distribute all over the organism, presenting high systemic toxicity and leading to undesired side effects on healthy tissues. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
2.
1 p, 620.2 KB Phage display : an aproximation to cancer-targeted nanomedicines / Sánchez-García, Laura ; Villaverde Corrales, Antonio, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Microbiologia [816]  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.